Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Disease Management for Schizophrenia

Disease management efforts for schizophrenia are less well established than are efforts for other chronic illnesses such as asthma and diabetes. Managing schizophrenia poses more of a challenge than many other chronic diseases because it usually causes greater disability than other mental and physical illnesses. However, disease management strategies have the potential to improve therapeutic outcomes for patients with schizophrenia. This monograph provides an introduction to disease management as well as examples of interventions for schizophrenia.

Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Blog Post

AMCP 2013 Nexus: Addressing Critical Pharmacy Issues

Specialty pharmacy, health care reform, clinical breakthroughs and research in managed care are among the featured topics at the AMCP 2013 Nexus, a...
Blog Post

NPC Request for Research Proposals on Individual Treatment Effects

NPC’s recent research, conferences and activities have explored the “myth” of the average patient, highlighting the policy, coverage and health...
Blog Post

CER Tweets of the Week (June 17-21, 2013)

The Patient-Centered Outcomes Research Institute (PCORI) built buzz on Twitter by launching the PCORI Engagement Awards program, which will grant...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council’s Chairman of the Board

WASHINGTON, DC (November 2, 2012)–The National Pharmaceutical Council (NPC) today announced that John Gargiulo, President & CEO, Daiichi Sankyo,...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

New Survey Shows Employers Eyeing CER, PCORI for Health Information

Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...
Commentary and Testimony Page

The Risks of Standardized Health Care

Think about the last time you visited a medical office. Even at a specialist’s office, chances are that each person waiting for his or her name to be...
Commentary and Testimony Page

Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals

Medications are more than an item on the balance sheet for health care providers. Pharmaceuticals offer a route to manage costs while achieving...
Commentary and Testimony Page

Linking Chronic Conditions to Medication Adherence and Productivity

It's no secret that chronic disease is the major driver of health care costs in the United States, accounting for two-thirds of the rise in health...
Commentary and Testimony Page

Employers Are Focusing on Improving Health Outcomes

Employers across the nation increasingly recognize that one of the best ways to improve productivity is to ensure the health and well-being of their...
YouTube Videos

Chronic Health Conditions & Individual Treatment Effects

Dr. Ken Thorpe, chairman of the Partnership to Fight Chronic Disease, explains that one of the biggest health care challenges is managing patients...
YouTube Videos

PCORI Outlines Efforts to Engage Patients

Dr. Rachael Fleurence, Scientist,Patient-Centered Outcomes Research Institute, outlines the many ways heragency is engaging patients and other...
YouTube Videos

UPenn's Dr. Caplan on Communicating CER to Patients

Univ. of Pennsylvania Director of the Center for Bioethics Dr. Art Caplan outlines an ethical framework for communicating comparative effectiveness...
YouTube Videos

Prioritizing CER: Assessing Public Health & Being Open With the Public

NPC Chief Science Officer Dr. Robert Dubois discusses an optimal decision-making process that could be utilized by research organizations in setting...
Blog Post

AMCP 2013 Nexus: Addressing Critical Pharmacy Issues

Specialty pharmacy, health care reform, clinical breakthroughs and research in managed care are among the featured topics at the AMCP 2013 Nexus, a...
Blog Post

NPC Request for Research Proposals on Individual Treatment Effects

NPC’s recent research, conferences and activities have explored the “myth” of the average patient, highlighting the policy, coverage and health...
Blog Post

CER Tweets of the Week (June 17-21, 2013)

The Patient-Centered Outcomes Research Institute (PCORI) built buzz on Twitter by launching the PCORI Engagement Awards program, which will grant...
Blog Post

The Role of Pharmaceuticals in the ACO Environment

Mark your calendars for October 16 from 2 pm-3pm ET and plan to participate in a special webinar about the role of pharmaceuticals in the accountable...

Research

The Myth of Average: Why Individual Patient Differences Matter

Within today’s health care environment, so much of t

Setting Priorities for Comparative Effectiveness Research: From Assessing Public Health Benefits to Being Open With the Public

NPC outlined several key considerations for prioritizing comparative effectiveness research,...

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research

By choosing "winners and losers," CER drug trials may leave patients who best respond to the "...
  •  
  • 1 of 37
  • >

Commentary & Testimony